SYCE3
gene geneOn this page
Summary
SYCE3 (synaptonemal complex central element protein 3, HGNC:35245) is a protein-coding gene on chromosome 22q13.33, encoding Synaptonemal complex central element protein 3 (A1L190). Major component of the transverse central element of synaptonemal complexes (SCS), formed between homologous chromosomes during meiotic prophase.
Predicted to be involved in reciprocal meiotic recombination; spermatogenesis; and synaptonemal complex assembly. Predicted to act upstream of or within positive regulation of apoptotic process; positive regulation of developmental process; and positive regulation of reproductive process. Predicted to be located in chromosome and nucleus. Predicted to be active in central element.
Source: NCBI Gene 644186 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 14 total
- MANE Select transcript:
NM_001123225
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:35245 |
| Approved symbol | SYCE3 |
| Name | synaptonemal complex central element protein 3 |
| Location | 22q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000217442 |
| Ensembl biotype | protein_coding |
| OMIM | 615775 |
| Entrez | 644186 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000402753, ENST00000406915
RefSeq mRNA: 1 — MANE Select: NM_001123225
NM_001123225
CCDS: CCDS46733
Canonical transcript exons
ENST00000406915 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001551934 | 50551112 | 50551402 |
| ENSE00001560608 | 50556297 | 50556405 |
| ENSE00001560886 | 50562858 | 50562919 |
Expression profiles
Bgee: expression breadth ubiquitous, 155 present calls, max score 97.83.
FANTOM5 (CAGE): breadth broad, TPM avg 0.4790 / max 146.6026, expressed in 186 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 194789 | 0.3504 | 131 |
| 194788 | 0.1126 | 37 |
| 194790 | 0.0160 | 3 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 97.83 | gold quality |
| right testis | UBERON:0004534 | 97.75 | gold quality |
| testis | UBERON:0000473 | 94.92 | gold quality |
| sperm | CL:0000019 | 94.70 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.27 | gold quality |
| adult organism | UBERON:0007023 | 88.30 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.71 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 74.04 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 66.81 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 66.72 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 66.43 | gold quality |
| granulocyte | CL:0000094 | 64.52 | gold quality |
| myocardium | UBERON:0002349 | 64.30 | gold quality |
| upper arm skin | UBERON:0004263 | 64.05 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 63.01 | gold quality |
| secondary oocyte | CL:0000655 | 62.25 | gold quality |
| islet of Langerhans | UBERON:0000006 | 61.58 | gold quality |
| substantia nigra | UBERON:0002038 | 61.52 | gold quality |
| putamen | UBERON:0001874 | 61.35 | gold quality |
| quadriceps femoris | UBERON:0001377 | 60.98 | gold quality |
| hypothalamus | UBERON:0001898 | 60.98 | gold quality |
| amygdala | UBERON:0001876 | 60.70 | gold quality |
| midbrain | UBERON:0001891 | 60.60 | gold quality |
| vastus lateralis | UBERON:0001379 | 60.26 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 60.10 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 60.03 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 59.86 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 59.38 | gold quality |
| spinal cord | UBERON:0002240 | 59.22 | gold quality |
| nucleus accumbens | UBERON:0001882 | 58.75 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 31.28 |
| E-ANND-3 | no | 1.67 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
4 targeting SYCE3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-361-3P | 99.19 | 66.45 | 1381 |
| HSA-MIR-4477A | 98.83 | 69.75 | 2952 |
| HSA-MIR-6821-3P | 95.21 | 66.79 | 578 |
Literature-anchored findings (GeneRIF, showing 1)
- Cloning and expression analysis of a similar gene in mouse. (PMID:19323366)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Syce3 | ENSMUSG00000078938 |
| rattus_norvegicus | Syce3 | ENSRNOG00000042056 |
Protein
Protein identifiers
Synaptonemal complex central element protein 3 — A1L190 (reviewed: A1L190)
Alternative names: Testis highly expressed gene 2 protein
All UniProt accessions (1): A1L190
UniProt curated annotations — full annotation on UniProt →
Function. Major component of the transverse central element of synaptonemal complexes (SCS), formed between homologous chromosomes during meiotic prophase. Required for the assembly of the central element of the synaptonemal complex during meiosis, via remodeling of SYCP1 lattice structures and promoting recruitment of SYCE2-TEX12 and SYCE1-SIX60S1 complexes. Required for chromosome loading of the central element-specific SCS proteins, and for initiating synapsis between homologous chromosomes. Chromosome loading appears to require SYCP1. Required for fertility and normal testis development.
Subunit / interactions. Homodimer. Can form higher-order homooligomers. Interacts with SYCP1 (via tetrameric core); the interaction remodels SYCP1 homotetramers to 2:1 heterotrimers with SYCE3. SYCP1/SYCE3 heterotrimers form lattice assemblies as part of the mature synaptonemal complex via both lateral and head-to-head interactions. Interacts with the SYCE1-SIX6OS1 complex; the interaction recruits the SYCE1-SIX6OS1 complex to the central element of the synaptonemal complex. Interacts with the SYCE2-TEX12 complex; the interaction promotes fibrous assembly of SYCE2-TEX12 as part of the synaptonemal complex central element. Interacts with SYCE1. Interacts with SYCE2. Interacts with proteasome subunit PSMA8; to participate in meiosis progression during spermatogenesis. Interacts with SPO16.
Subcellular location. Nucleus. Chromosome.
RefSeq proteins (1): NP_001116697* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028145 | Synaptonemal_3 | Family |
Pfam: PF15191
UniProt features (6 total): mutagenesis site 3, chain 1, coiled-coil region 1, sequence variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6H86 | X-RAY DIFFRACTION | 1.9 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A1L190-F1 | 93.66 | 0.85 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 41 | abolishes formation of higher-order homooligomers; when associated with e-44. abolishes interaction between sycp1/syce3 |
| 44 | abolishes formation of higher-order homooligomers; when associated with e-41. abolishes interaction between sycp1/syce3 |
| 53 | promotes formation of higher-order homooligomers. |
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-1221632 | Meiotic synapsis |
| R-HSA-1474165 | Reproduction |
| R-HSA-1500620 | Meiosis |
| R-HSA-1640170 | Cell Cycle |
MSigDB gene sets: 53 (showing top):
GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, GOBP_CHROMOSOME_ORGANIZATION, REACTOME_MEIOTIC_SYNAPSIS, GOBP_MALE_GAMETE_GENERATION, GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION, GOBP_ORGANELLE_FISSION, GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS, GOBP_NUCLEAR_CHROMOSOME_SEGREGATION, GOBP_MEIOTIC_CELL_CYCLE, GOBP_CELL_DIVISION, chr22q13
GO Biological Process (10): apoptotic process (GO:0006915), synaptonemal complex assembly (GO:0007130), reciprocal meiotic recombination (GO:0007131), spermatogenesis (GO:0007283), ectopic germ cell programmed cell death (GO:0035234), positive regulation of apoptotic process (GO:0043065), positive regulation of developmental process (GO:0051094), cell division (GO:0051301), positive regulation of reproductive process (GO:2000243), meiotic cell cycle (GO:0051321)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): central element (GO:0000801), nucleus (GO:0005634), chromosome (GO:0005694)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Meiosis | 1 |
| Reproduction | 1 |
| Cell Cycle | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 2 |
| positive regulation of biological process | 2 |
| reproductive process | 2 |
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| homologous chromosome pairing at meiosis | 1 |
| cellular component assembly | 1 |
| chromosome organization involved in meiotic cell cycle | 1 |
| synaptonemal complex organization | 1 |
| meiosis I | 1 |
| reciprocal homologous recombination | 1 |
| meiotic cell cycle process | 1 |
| male gamete generation | 1 |
| programmed cell death involved in cell development | 1 |
| apoptotic process | 1 |
| regulation of apoptotic process | 1 |
| positive regulation of programmed cell death | 1 |
| developmental process | 1 |
| regulation of developmental process | 1 |
| cellular process | 1 |
| regulation of reproductive process | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| meiotic nuclear division | 1 |
| binding | 1 |
| synaptonemal complex | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
695 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SYCE3 | SYCE2 | Q6PIF2 | 983 |
| SYCE3 | SYCE1 | Q8N0S2 | 973 |
| SYCE3 | TEX12 | Q9BXU0 | 969 |
| SYCE3 | SYCP1 | Q15431 | 938 |
| SYCE3 | SYCP3 | Q8IZU3 | 902 |
| SYCE3 | C14orf39 | Q8N1H7 | 822 |
| SYCE3 | SYCP2 | Q9BX26 | 796 |
| SYCE3 | HORMAD1 | Q86X24 | 732 |
| SYCE3 | MEIOB | Q8N635 | 646 |
| SYCE3 | STAG3 | Q9UJ98 | 625 |
| SYCE3 | SPATA22 | Q8NHS9 | 617 |
| SYCE3 | SMC1B | Q8NDV3 | 565 |
| SYCE3 | HORMAD2 | Q8N7B1 | 539 |
| SYCE3 | REC8 | O95072 | 537 |
| SYCE3 | SPO11 | Q9Y5K1 | 530 |
IntAct
54 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SYCE3 | HAUS1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| HAUS1 | SYCE3 | psi-mi:“MI:0915”(physical association) | 0.670 |
| BLOC1S6 | SYCE3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYCE3 | BLOC1S6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYCE3 | PKN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYCE3 | KRT79 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYCE3 | SGF29 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYCE3 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| SYCE3 | PRPS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYCE3 | WFS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLF11 | SYCE3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUP58 | SYCE3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYCE3 | HTT | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (99): SYCE3 (Two-hybrid), SYCE3 (Two-hybrid), CENPE (Affinity Capture-MS), MAP3K15 (Affinity Capture-MS), SCLT1 (Affinity Capture-MS), NIN (Affinity Capture-MS), SASS6 (Affinity Capture-MS), RUNX1T1 (Affinity Capture-MS), PRDM6 (Affinity Capture-MS), KIFC3 (Affinity Capture-MS), KIZ (Affinity Capture-MS), PEX11B (Affinity Capture-MS), FEM1B (Affinity Capture-MS), HAUS3 (Affinity Capture-MS), RB1CC1 (Affinity Capture-MS)
ESM2 similar proteins: A0R9B0, A1L190, A4GBY2, A4GCK2, A4GCL3, A4GCM4, A4IKB8, A4K148, A4U6V7, A4U7B1, A7GKT9, A7Z2G8, A9VSL6, B5KM66, B7H7K5, B7HTZ9, B7IVV9, B7JNA2, B9J2P7, C1EWA3, C3L658, C3PCM9, C5D5A9, O35041, P03504, P11619, P69259, P69260, P69266, P69267, P71080, P85939, Q18446, Q1K9P8, Q3ZC61, Q5L2X7, Q5RK03, Q5WFM7, Q63GH2, Q65MG3
Diamond homologs: A1L190, B5KM66
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| SYCE3 | “form complex” | Synaptonemal_complex | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
378 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:50551398:CTGCA:C | acceptor_gain | 1.0000 |
| 22:50551399:TGCA:T | acceptor_gain | 1.0000 |
| 22:50551400:GCACT:G | acceptor_loss | 1.0000 |
| 22:50551402:ACTGC:A | acceptor_loss | 1.0000 |
| 22:50551403:C:CC | acceptor_gain | 1.0000 |
| 22:50551403:CTGC:C | acceptor_loss | 1.0000 |
| 22:50551404:T:A | acceptor_loss | 1.0000 |
| 22:50556292:CCTA:C | donor_loss | 1.0000 |
| 22:50556293:CTA:C | donor_loss | 1.0000 |
| 22:50556294:TACC:T | donor_loss | 1.0000 |
| 22:50556295:A:AT | donor_loss | 1.0000 |
| 22:50556296:C:CT | donor_loss | 1.0000 |
| 22:50556413:A:AC | acceptor_gain | 1.0000 |
| 22:50551400:GCA:G | acceptor_gain | 0.9900 |
| 22:50551401:CA:C | acceptor_gain | 0.9900 |
| 22:50551401:CAC:C | acceptor_gain | 0.9900 |
| 22:50551409:C:CT | acceptor_gain | 0.9900 |
| 22:50556401:TCCAT:T | acceptor_gain | 0.9900 |
| 22:50556402:CCAT:C | acceptor_gain | 0.9900 |
| 22:50556402:CCATC:C | acceptor_gain | 0.9900 |
| 22:50556403:CAT:C | acceptor_gain | 0.9900 |
| 22:50556403:CATC:C | acceptor_gain | 0.9900 |
| 22:50556405:TCT:T | acceptor_loss | 0.9900 |
| 22:50556406:C:CC | acceptor_gain | 0.9900 |
| 22:50556406:C:T | acceptor_loss | 0.9900 |
| 22:50556407:T:C | acceptor_loss | 0.9900 |
| 22:50556411:C:CT | acceptor_gain | 0.9900 |
| 22:50556412:A:T | acceptor_gain | 0.9900 |
| 22:50556413:A:C | acceptor_gain | 0.9900 |
| 22:50556416:C:CT | acceptor_gain | 0.9900 |
AlphaMissense
591 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:50551397:C:G | A39P | 0.985 |
| 22:50551319:C:G | A65P | 0.982 |
| 22:50551363:C:G | R50P | 0.982 |
| 22:50551314:G:C | F66L | 0.981 |
| 22:50551314:G:T | F66L | 0.981 |
| 22:50551316:A:G | F66L | 0.981 |
| 22:50551385:C:G | A43P | 0.981 |
| 22:50551384:G:T | A43D | 0.979 |
| 22:50556308:T:A | E33V | 0.977 |
| 22:50556344:A:G | L21P | 0.977 |
| 22:50551364:G:T | R50S | 0.976 |
| 22:50551378:T:A | D45V | 0.976 |
| 22:50551386:C:A | M42I | 0.974 |
| 22:50551386:C:G | M42I | 0.974 |
| 22:50551386:C:T | M42I | 0.974 |
| 22:50551327:A:G | L62P | 0.972 |
| 22:50551302:C:A | K70N | 0.965 |
| 22:50551302:C:G | K70N | 0.965 |
| 22:50556323:A:G | L28P | 0.965 |
| 22:50556332:A:G | L25S | 0.965 |
| 22:50551382:A:C | Y44D | 0.963 |
| 22:50551387:A:G | M42T | 0.957 |
| 22:50551391:A:G | W41R | 0.957 |
| 22:50551391:A:T | W41R | 0.957 |
| 22:50551378:T:G | D45A | 0.956 |
| 22:50551305:G:C | C69W | 0.955 |
| 22:50551375:A:C | M46R | 0.955 |
| 22:50556307:C:A | E33D | 0.955 |
| 22:50556307:C:G | E33D | 0.955 |
| 22:50551372:A:T | V47E | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000018363 (22:50561473 A>G), RS1000521753 (22:50564667 T>C), RS1000559790 (22:50557128 T>C), RS1000775439 (22:50550655 G>A), RS1000909837 (22:50556835 A>G), RS1001288315 (22:50564112 A>C), RS1001646120 (22:50563142 T>G), RS1001695566 (22:50564325 A>G), RS1001698403 (22:50563503 C>A), RS1002496754 (22:50550890 C>A,T), RS1002579780 (22:50559915 A>C), RS1002624494 (22:50552330 ACT>A), RS1002635782 (22:50551631 T>TTCTGGATACACATG), RS1002640905 (22:50558480 C>G), RS1002784199 (22:50553144 G>A,C)
Disease associations
OMIM: gene MIM:615775 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004602_305 | Mean corpuscular volume | 4.000000e-39 |
| GCST004630_50 | Mean corpuscular hemoglobin | 6.000000e-25 |
| GCST90002390_287 | Mean corpuscular hemoglobin | 4.000000e-12 |
| GCST90002392_233 | Mean corpuscular volume | 9.000000e-19 |
| GCST90002396_97 | Mean reticulocyte volume | 6.000000e-22 |
| GCST90002397_615 | Mean spheric corpuscular volume | 2.000000e-26 |
| GCST90002403_711 | Red blood cell count | 6.000000e-10 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0010701 | mean reticulocyte volume |
| EFO:0004305 | erythrocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| Vorinostat | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Particulate Matter | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.